journal article·2022Open access

A self-assembling peptidic platform to boost the cellular uptake and nuclear delivery of oligonucleotides

Shabnam Tarvirdipour, Michal Skowicki, Cora-Ann Schoenenberger, Larisa E. Kapinos, Roderick Y. H. Lim, Yaakov Benenson, Cornelia G. Palivan

Biomaterials Science· Volume 10· Issue 15

Abstract

The design of non-viral vectors that efficiently deliver genetic materials into cells, in particular to the nucleus, remains a major challenge in gene therapy and vaccine development. To tackle the problems associated with cellular uptake and nuclear targeting, here we introduce a delivery platform based on the self-assembly of an amphiphilic peptide carrying an N-terminal KRKR sequence that functions as a nuclear localization signal (NLS). By means of a single-step self-assembly process, the amphiphilic peptides afford the generation of NLS-functionalized multicompartment micellar nanostructures that can embed various oligonucleotides between their individual compartments. Detailed physicochemical, cellular and ultrastructural analyses demonstrated that integrating an NLS in the hydrophilic domain of the peptide along with tuning its hydrophobic domain led to self-assembled DNA-loaded multicompartment micelles (MCMs) with enhanced cellular uptake and nuclear translocation. We showed that the nuclear targeting ensued via the NLS interaction with the nuclear transport receptors of the karyopherin family. Importantly, we observed that the treatment of MCF-7 cells with NLS-MCMs loaded with anti-BCL2 antisense oligonucleotides resulted in up to 86% knockdown of BCL2, an inhibitor of apoptosis that is overexpressed in more than half of all human cancers. We envision that this platform can be used to efficiently entrap and deliver diverse genetic payloads to the nucleus and find applications in basic research and biomedicine.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · DNA and Nucleic Acid Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, University of Basel, Basel, CH-4058, Switzerland

Swiss Nanoscience Institute (SNI), University of Basel, Basel, CH-4056, Switzerland

Department of Biosystems Science and Engineering, ETH Zurich, Basel, CH-4058, Switzerland

Biozentrum, University of Basel, Basel, CH-4056 Switzerland

Funding

Swiss Nanoscience Institute · Universität Basel · Eidgenössische Technische Hochschule Zürich

References (73)

Show source-provided references
1. Anna · J. Appl. Genet. · 2018 · 59 · 25310.1007/s13353-018-0444-7 ↗
2. Geyer · Curr. Opin. Cell Biol. · 2011 · 23 · 35410.1016/j.ceb.2011.03.002 ↗
3. Zwerger · Annu. Rev. Biomed. Eng. · 2011 · 13 · 39710.1146/annurev-bioeng-071910-124736 ↗
4. Parodi · Nanomedicine · 2015 · 10 · 192310.2217/nnm.15.39 ↗
5. Wagstaff · Biochem. J. · 2007 · 406 · 18510.1042/BJ20070505 ↗
6. Xu · Curr. Opin. Struct. Biol. · 2010 · 20 · 78210.1016/j.sbi.2010.09.008 ↗
7. Zelmer · Proc. Natl. Acad. Sci. U. S. A. · 2020 · 117 · 277010.1073/pnas.1916395117 ↗
8. Thapa · Curr. Opin. Biomed. Eng. · 2018 · 7 · 7110.1016/j.cobme.2018.10.002 ↗
9. Dean · Gene Ther. · 2005 · 12 · 88110.1038/sj.gt.3302534 ↗
10. Jones · Mol. Pharm. · 2013 · 10 · 408210.1021/mp400467x ↗
11. J. M.Tomich , E.Wessel , J.Choi and L. A.Avila , in Nucleic Acid Nanotheranostics , ed. M. Filice and J. Ruiz-Cabello , Elsevier , 2019 , pp. 247–27610.1016/B978-0-12-814470-1.00008-3 ↗
12. Cheng · Angew. Chem. · 2019 · 131 · 510310.1002/ange.201901527 ↗
13. Yi · Bioconjugate Chem. · 2012 · 23 · 12510.1021/bc2005472 ↗
14. Bogacheva · Bioorg. Med. Chem. Lett. · 2017 · 27 · 478110.1016/j.bmcl.2017.10.001 ↗
15. Bhattacharjee · Ther. Delivery · 2021 · 12 · 2110.4155/tde-2020-0099 ↗
16. W. C. W.Chan , Bio-Applications of Nanoparticles , Springer Science & Business Media , 2009
17. Tenchov · ACS Nano · 2021 · 15 · 1698210.1021/acsnano.1c04996 ↗
18. Sharma · Int. J. Biol. Macromol. · 2021 · 183 · 205510.1016/j.ijbiomac.2021.05.192 ↗
19. Saffari · Iran. J. Pharm. Res. · 2016 · 15 · 3
20. Chen · Bioact. Mater. · 2019 · 4 · 12010.1016/j.bioactmat.2019.01.002 ↗
21. Tarvirdipour · Int. J. Mol. Sci. · 2021 · 22 · 909210.3390/ijms22169092 ↗
22. Rad-Malekshahi · Bioconjugate Chem. · 2016 · 27 · 310.1021/acs.bioconjchem.5b00487 ↗
23. Qiu · Int. J. Nanomed. · 2018 · 13 · 500310.2147/IJN.S166403 ↗
24. Li · Bioact. Mater. · 2022 · 11 · 26810.1016/j.bioactmat.2021.09.029 ↗
25. Tarvirdipour · Molecules · 2020 · 25 · 348210.3390/molecules25153482 ↗
26. Do · FEBS Lett. · 2006 · 580 · 186510.1016/j.febslet.2006.02.049 ↗
27. Beg · Genes Dev. · 1992 · 6 · 189910.1101/gad.6.10.1899 ↗
28. Lokareddy · Structure · 2015 · 23 · 130510.1016/j.str.2015.04.017 ↗
29. Kosugi · J. Biol. Chem. · 2009 · 284 · 47810.1074/jbc.M807017200 ↗
30. O'Day · Cells · 2019 · 8 · 16710.3390/cells8020167 ↗
31. Li · J. Virol. · 2009 · 83 · 253110.1128/JVI.02209-08 ↗
32. Catalano · Histochem. Cell Biol. · 2012 · 138 · 51510.1007/s00418-012-0973-9 ↗
33. Desale · Biomater. Sci. · 2021 · 9 · 115310.1039/D0BM01755H ↗
34. Tarvirdipour · Soft Matter · 2020 · 16 · 167810.1039/C9SM01990A ↗
35. S.Sharad , Antisense Therapy: An Overview , IntechOpen , 201910.5772/intechopen.73736 ↗
36. Doxakis · Med. Res. Rev. · 2021 · 41 · 265610.1002/med.21706 ↗
37. Batista-Duharte · Biomolecules · 2020 · 10 · 31610.3390/biom10020316 ↗
38. Badros · J. Clin. Oncol. · 2005 · 23 · 408910.1200/JCO.2005.14.381 ↗
39. Morris · Clin. Cancer Res. · 2002 · 8 · 679
40. Cheng · Pharm. Res. · 2017 · 34 · 31010.1007/s11095-016-2063-5 ↗
41. Kapinos · Biophys. J. · 2014 · 106 · 175110.1016/j.bpj.2014.02.021 ↗
42. Kapinos · J. Cell Biol. · 2017 · 216 · 360910.1083/jcb.201702092 ↗
43. Schoch · Proc. Natl. Acad. Sci. U. S. A. · 2012 · 109 · 1691110.1073/pnas.1208440109 ↗
44. Bernhard · J. Ultrastruct. Res. · 1969 · 27 · 25010.1016/S0022-5320(69)80016-X ↗
45. Yao · J. Drug Targeting · 2013 · 21 · 92610.3109/1061186X.2013.830310 ↗
46. Durymanov · Front. Pharmacol. · 2018 · 9 · 97110.3389/fphar.2018.00971 ↗
47. Schuster · Soft Matter · 2010 · 6 · 559610.1039/c0sm00442a ↗
48. Brendel · Polym. Chem. · 2019 · 10 · 261610.1039/C9PY00179D ↗
49. Hoshyar · Nanomedicine · 2016 · 11 · 67310.2217/nnm.16.5 ↗
50. Honary · Trop. J. Pharm. Res. · 2013 · 12 · 265
51. Anderson · Cancer Gene Ther. · 2006 · 13 · 40610.1038/sj.cgt.7700901 ↗
52. Marshall · Ann. Oncol. · 2004 · 15 · 127410.1093/annonc/mdh317 ↗
53. Xu · ACS Appl. Mater. Interfaces · 2021 · 13 · 1076010.1021/acsami.1c00016 ↗
54. Bulut · Biomacromolecules · 2011 · 12 · 300710.1021/bm200641e ↗
55. Marfori · Biochim. Biophys. Acta, Mol. Cell Res. · 2011 · 1813 · 156210.1016/j.bbamcr.2010.10.013 ↗
56. Sakiyama · Nat. Nanotechnol. · 2016 · 11 · 71910.1038/nnano.2016.62 ↗
57. Davis · bioRxiv · 2021 · 120 · 1565
58. Fagerlund · J. Biol. Chem. · 2002 · 277 · 3007210.1074/jbc.M202943200 ↗
59. Bourgeois · Proc. Natl. Acad. Sci. U. S. A. · 2020 · 117 · 850310.1073/pnas.1918944117 ↗
60. Gonzalez · Sci. Rep. · 2021 · 11 · 375410.1038/s41598-021-83196-y ↗
61. Auría-Soro · Nanomaterials · 2019 · 9 · 136510.3390/nano9101365 ↗
62. Huang · Sci. Adv. · 2020 · 6 · eaba132110.1126/sciadv.aba1321 ↗
63. Manzanares · Pharmaceutics · 2020 · 12 · 37110.3390/pharmaceutics12040371 ↗
64. Zhou · J. Mater. Chem. B · 2020 · 8 · 556410.1039/D0TB00498G ↗
65. Gessner · Int. J. Mol. Sci. · 2020 · 21 · 253610.3390/ijms21072536 ↗
66. Silva · Biomolecules · 2019 · 9 · 2210.3390/biom9010022 ↗
67. Foroozandeh · Nanoscale Res. Lett. · 2018 · 13 · 33910.1186/s11671-018-2728-6 ↗
68. Aramburu · Semin. Cell Dev. Biol. · 2017 · 68 · 3410.1016/j.semcdb.2017.06.026 ↗
69. Zimmerli · Science · 2021 · 374 · eabd977610.1126/science.abd9776 ↗
70. Liang · Mol. Ther. · 2017 · 25 · 207510.1016/j.ymthe.2017.06.002 ↗
71. Lee · J. Biomater. Sci., Polym. Ed. · 2021 · 32 · 114010.1080/09205063.2021.1909411 ↗
72. Li · Colloids Surf., B · 2019 · 184 · 11051010.1016/j.colsurfb.2019.110510 ↗
73. Park · Cytotherapy · 2015 · 17 · 53610.1016/j.jcyt.2014.11.008 ↗